Patient population for the NAVIGATE trial is based on non-invasive tests and clinical criteria utilizing latest treatment guidelines for portal ...

Since MELD 3.0 was implemented in July 2023, a higher proportion of women are now on the liver transplant waitlist, and ...

Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed ...

Since the adoption of a new model for assessing the severity of liver disease, women are more likely to be added to the ...

Among 64 patients who received immune checkpoint inhibitors, 78% had downstaging of their liver tumor to within Milan ...

The research found beer consumers have lower-quality diets, are less active and are more likely to smoke cigarettes compared ...

INTEGRIS-PSC featured in an oral late breaker presentationSOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, ...

Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed ...

Salix Pharmaceuticals ("Salix"), today announced the first look at its late-stage RED-C clinical trial program which will be presented at the American Association for the Study of Liver Disease (AASLD ...

Designed to treat end-stage liver disease, the company has been granted permission from the Spanish authorities to expand its ...

Given the increasing prevalence and mortality rates, targeted strategies are needed to reduce this growing health burden in ...